Cargando…
Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis
Psoriatic arthritis is a part of the family of diseases referred to as spondyloarthropathies, a diverse group of chronic inflammatory disorders with common clinical, radiographic, and genetic features. Peripheral arthritis is the most common symptom of psoriatic arthritis and patients also frequentl...
Autores principales: | Bergman, Martin, Lundholm, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359960/ https://www.ncbi.nlm.nih.gov/pubmed/28320454 http://dx.doi.org/10.1186/s13075-017-1265-5 |
Ejemplares similares
-
Managing morbidity and treatment-related toxicity in patients with ankylosing spondylitis
por: Bergman, Martin, et al.
Publicado: (2018) -
Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
por: Mease, Philip J., et al.
Publicado: (2014) -
Cardiovascular Risk in Patients with Psoriatic Arthritis
por: Zhu, Tracy Y., et al.
Publicado: (2012) -
Treatment guidelines in psoriatic arthritis
por: Ogdie, Alexis, et al.
Publicado: (2020) -
Upadacitinib for the treatment of psoriatic arthritis
por: Fonseca, Diogo, et al.
Publicado: (2023)